- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- ICO Paul Papin Angers, France
- CH d'Avignon Avignon, France
- Sainte-Catherine Institut du Cancer Avignon-Provence Avignon, France
- Hôpital de la Côte Basque Bayonne, France
Clinical trial condition
Urogenital Neoplasms
Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.
12,007 public trials
2,555 recruiting studies
Urogenital Neoplasms trial results
NCT06076538
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT06245603
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Humanitas Gavezzeni-Bergamo Bergamo, Italy
- Ospedale Sant'Orsola - Malpighi Bologna, Italy
- Policlinico Ospedali Riuniti - Foggia Foggia, Italy
- Istituto Oncologico Veneto IRCCS Padova, Italy
NCT07719361
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +15 more
- Locations
-
- START Los Angeles Los Angeles, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- START Midwest Grand Rapids, Michigan, United States
- START New Jersey East Brunswick, New Jersey, United States
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
- Conditions
- Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
- Locations
-
- USOR HonorHealth Phoenix, Arizona, United States
- USOR Arizona Oncology Associates Tucson, Arizona, United States
- University of California Los Angeles Medical Center Los Angeles, California, United States
- University of California, San Diego; Moores Cancer Center San Diego, California, United States
NCT06960577
- Conditions
- Cisplatin, Doxorubicin, Female Urogenital Diseases, +14 more
- Locations
-
- Research Site Chermside, Australia
- Research Site Elizabeth Vale, Australia
- Research Site Heidelberg, Australia
- Research Site Hong Kong, Australia
Recruiting
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
NCT06801236
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
- Locations
-
- University of California San Diego, Moores Cancer Center La Jolla, California, United States
- Moffitt Cancer Center, Tampa Tampa, Florida, United States
- University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
- Harvard Medical School-Massachusetts General Hospital Boston, Massachusetts, United States
NCT07364071
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- University of California San Diego La Jolla, California, United States
NCT07743749
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, China
NCT05603910
- Conditions
- Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- University of Miami Miami, Florida, United States